News >

New Era Begins of Molecular Monitoring and Targeted Therapy in AML

Caroline Seymour
Published: Thursday, May 02, 2019

Eric S. Winer, MD

Eric S. Winer, MD

In the current era of acute myeloid leukemia (AML), treatment plans can be tailored based on each patient’s molecular profile, which is far more than what cytogenetics allowed for, explained Eric S. Winer, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x